Role for proteases and protease-activated receptor-2 (par2) in pain associated with irritable bowel syndrome (IBS)

被引：0
|
作者：
Cenac, N
Chapman, K
Andrade-Gordon, P
Ferraz, JG
Andrews, C
Shaffer, E
Vergnolle, N
机构：
来源：
GASTROENTEROLOGY | 2005年 / 128卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A14 / A14
页数：1
相关论文
共 50 条
  • [1] Protease-activated receptor-2 (PAR2) in the airways
    Cocks, TM
    Moffatt, JD
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2001, 14 (03) : 183 - 191
  • [2] Protease-activated Receptor-2 (PAR2) in Human Periodontitis
    Holzhausen, M.
    Cortelli, J. R.
    Araujo da Silva, V.
    Nobre Franco, G. C.
    Cavalca Cortelli, S.
    Vergnolle, N.
    JOURNAL OF DENTAL RESEARCH, 2010, 89 (09) : 948 - 953
  • [3] Protease-activated receptor-2 (PAR2) in cardiovascular system
    Bucci, M
    Roviezzo, F
    Cirino, G
    VASCULAR PHARMACOLOGY, 2005, 43 (04) : 247 - 253
  • [4] Protease-activated receptor-2 in endosomes signals persistent pain of irritable bowel syndrome
    Jimenez-Vargas, Nestor N.
    Pattison, Luke A.
    Zhao, Peishen
    Lieu, TinaMarie
    Latorre, Rocco
    Jensen, Dane D.
    Castro, Joel
    Aurelio, Luigi
    Le, Giang T.
    Flynn, Bernard
    Herenbrink, Carmen Klein
    Yeatman, Holly R.
    Edgington-Mitchell, Laura
    Porter, Christopher J. H.
    Halls, Michelle L.
    Canals, Meritxell
    Veldhuis, Nicholas A.
    Poole, Daniel P.
    McLean, Peter
    Hicks, Gareth A.
    Scheff, Nicole
    Chen, Elyssa
    Bhattacharya, Aditi
    Schmidt, Brian L.
    Brierley, Stuart M.
    Vanner, Stephen J.
    Bunnett, Nigel W.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2018, 115 (31) : E7438 - E7447
  • [5] Does protease-activated receptor-2 (PAR2) influence muscle development and regeneration?
    Esfandouni, N. Taghavi
    Mackie, E.
    Pagel, C.
    NEUROMUSCULAR DISORDERS, 2015, 25 : S218 - S219
  • [6] Predictive value of protease-activated receptor-2 (PAR2) in cervical cancer metastasis
    He, Shengnan
    Xu, Meiquan
    Xiong, Zhen
    Hu, Ye
    Huo, Qin
    Lu, Jingxiao
    Lin, Yuntao
    Yang, Lan
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2021, 25 (03) : 1415 - 1424
  • [7] Toward Drugs for Protease-Activated Receptor 2 (PAR2)
    Yau, Mei-Kwan
    Liu, Ligong
    Fairlie, David P.
    JOURNAL OF MEDICINAL CHEMISTRY, 2013, 56 (19) : 7477 - 7497
  • [8] Protease-Activated Receptor-2 (PAR2)-A Novel Therapeutic Target in Nonalcoholic Steatohepatitis (NASH)
    Shearer, Andrew M.
    Austin, Karyn
    Guha, Srijoy
    Nga Nguyen
    Looby, Richard
    Clappin, Allyson
    Baleja, James
    Covic, Lidija
    Kuliopulos, Athan
    HEPATOLOGY, 2014, 60 : 587A - 587A
  • [9] Differences in protease-activated receptor-2 (PAR2)-mediated vasodilation in a rat model of metabolic syndrome with increasing age
    Maruyama, Kana
    Kagota, Satomi
    Wakuda, Hirokazu
    McGuire, John. J.
    Yoshikawa, Noriko
    Nakamura, Kazuki
    Kunitomo, Masaru
    Shinozuka, Kazumasa
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2013, 121 : 164P - 164P
  • [10] Pepducin - A Novel Protease-Activated Receptor-2 (par2) Inhibitor - Attenuates Experimental Pulmonary Hypertension
    Warburton, R.
    Kuliopulos, A.
    Wieschhaus, A.
    Kayyali, U. S.
    Toksoz, D.
    Fanburg, B. L.
    Preston, I. R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
12345